Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001034569) PANCREATITIS REMEDIES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/034569 International Application No.: PCT/JP2000/007799
Publication Date: 17.05.2001 International Filing Date: 06.11.2000
Chapter 2 Demand Filed: 26.04.2001
IPC:
A61K 31/495 (2006.01) ,C07D 213/74 (2006.01) ,C07D 295/092 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
213
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02
having three double bonds between ring members or between ring members and non-ring members
04
having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
60
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
72
Nitrogen atoms
74
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
295
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
04
with substituted hydrocarbon radicals attached to ring nitrogen atoms
08
substituted by singly bound oxygen or sulfur atoms
084
with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
092
with aromatic radicals attached to the chain
Applicants:
OGATA, Kazumi [JP/JP]; JP (UsOnly)
OGINO, Shinya [JP/JP]; JP (UsOnly)
ITO, Kazuhiko [JP/JP]; JP (UsOnly)
SENJU PHARMACEUTICAL CO., LTD. [JP/JP]; 5-8, Hiranomachi 2-chome, Chuo-ku Osaka-shi, Osaka 541-0046, JP (AllExceptUS)
Inventors:
OGATA, Kazumi; JP
OGINO, Shinya; JP
ITO, Kazuhiko; JP
Agent:
HAYASAKA, Takumi; Hayasaka International Patent 2nd Fl., Kitahama-heiwa Bldg. 5-13, Kitahama 2-chome, chuo-ku Osaka-shi, Osaka 541-0041, JP
Priority Data:
11/32182111.11.1999JP
Title (EN) PANCREATITIS REMEDIES
(FR) MEDICAMENTS CONTRE LA PANCREATITE
Abstract:
(EN) Pancreatitis remedies containing as the active ingredient compounds of general formula (I) or pharmaceutically acceptable salts thereof wherein R1 and R2 are each independently hydrogen or lower alkyl, or alternatively R1 and R2 may together represent -(CH2)2-NH-(CH2)2-; R3 is hydrogen or lower alkyl; R4, R5 and R6 are each independently hydrogen, lower alkyl, lower alkoxy, halogeno, amino, or trifluoromethyl; and W1 and W2 are each independently nitrogen or carbon.
(FR) La présente invention concerne des médicaments contre la pancréatite et dont le principe actif est un composé tel que ceux représentés par la formule générale (I) ou l'un de ses sels pharmaceutiquement admis. Dans cette formule, R1 et R2, qui sont généralement chacun indépendamment hydrogène ou alkyle inférieur, peuvent également former ensemble un -(CH2)2-NH-(CH2)2-. R3 est hydrogène ou alkyle inférieur. R4, R5 et R6 sont chacun indépendamment hydrogène, alkyle inférieur, alcoxy inférieur, halogéno, amino, ou trifluorométhyle. Enfin W1 et W2 sont chacun indépendamment azote ou carbone.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)